ATE71300T1 - Mittel mit antidepressiver wirkung. - Google Patents
Mittel mit antidepressiver wirkung.Info
- Publication number
- ATE71300T1 ATE71300T1 AT88102785T AT88102785T ATE71300T1 AT E71300 T1 ATE71300 T1 AT E71300T1 AT 88102785 T AT88102785 T AT 88102785T AT 88102785 T AT88102785 T AT 88102785T AT E71300 T1 ATE71300 T1 AT E71300T1
- Authority
- AT
- Austria
- Prior art keywords
- depressive agents
- depressive
- agents
- compound
- antidepressive
- Prior art date
Links
- 239000000935 antidepressant agent Substances 0.000 title 1
- 229940126062 Compound A Drugs 0.000 abstract 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dental Preparations (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873706399 DE3706399A1 (de) | 1987-02-27 | 1987-02-27 | Mittel mit antidepressiver wirkung |
| EP88102785A EP0280290B1 (de) | 1987-02-27 | 1988-02-25 | Mittel mit antidepressiver Wirkung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE71300T1 true ATE71300T1 (de) | 1992-01-15 |
Family
ID=6321945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88102785T ATE71300T1 (de) | 1987-02-27 | 1988-02-25 | Mittel mit antidepressiver wirkung. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US4931435A (OSRAM) |
| EP (1) | EP0280290B1 (OSRAM) |
| JP (1) | JPS63238019A (OSRAM) |
| KR (1) | KR880009647A (OSRAM) |
| AT (1) | ATE71300T1 (OSRAM) |
| AU (1) | AU605554B2 (OSRAM) |
| CA (1) | CA1317229C (OSRAM) |
| DE (2) | DE3706399A1 (OSRAM) |
| DK (1) | DK102988A (OSRAM) |
| GR (1) | GR3003657T3 (OSRAM) |
| HU (1) | HU200919B (OSRAM) |
| IL (1) | IL85560A (OSRAM) |
| NZ (1) | NZ223670A (OSRAM) |
| ZA (1) | ZA881366B (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3386500A (en) | 1999-03-02 | 2000-09-21 | Merck & Co., Inc. | 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity |
| AU3389300A (en) * | 1999-03-02 | 2000-09-21 | Merck & Co., Inc. | Pyrrolidine modulators of chemokine receptor activity |
| US6489354B1 (en) | 1999-03-02 | 2002-12-03 | Merck & Co., Inc. | 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity |
| TW200517114A (en) | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3301759A (en) * | 1965-05-26 | 1967-01-31 | Robins Co Inc A H | Analeptic compositions and method |
| CA1115212A (en) * | 1978-02-10 | 1981-12-29 | Emilio Kyburz | Pyrrolidine derivatives |
| DE3326724A1 (de) * | 1983-07-25 | 1985-02-07 | Boehringer Ingelheim KG, 6507 Ingelheim | In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte |
| DE3336024A1 (de) * | 1983-10-04 | 1985-04-18 | Boehringer Ingelheim KG, 6507 Ingelheim | 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel |
-
1987
- 1987-02-27 DE DE19873706399 patent/DE3706399A1/de not_active Withdrawn
-
1988
- 1988-02-25 DE DE8888102785T patent/DE3867501D1/de not_active Expired - Lifetime
- 1988-02-25 EP EP88102785A patent/EP0280290B1/de not_active Expired - Lifetime
- 1988-02-25 AT AT88102785T patent/ATE71300T1/de not_active IP Right Cessation
- 1988-02-26 DK DK102988A patent/DK102988A/da not_active Application Discontinuation
- 1988-02-26 KR KR1019880001966A patent/KR880009647A/ko not_active Ceased
- 1988-02-26 IL IL85560A patent/IL85560A/xx unknown
- 1988-02-26 HU HU88926A patent/HU200919B/hu not_active IP Right Cessation
- 1988-02-26 US US07/160,730 patent/US4931435A/en not_active Expired - Fee Related
- 1988-02-26 ZA ZA881366A patent/ZA881366B/xx unknown
- 1988-02-26 CA CA000559893A patent/CA1317229C/en not_active Expired - Fee Related
- 1988-02-26 AU AU12352/88A patent/AU605554B2/en not_active Ceased
- 1988-02-26 NZ NZ223670A patent/NZ223670A/en unknown
- 1988-02-26 JP JP63044060A patent/JPS63238019A/ja active Pending
-
1991
- 1991-09-06 US US07/756,011 patent/US5217967A/en not_active Expired - Fee Related
-
1992
- 1992-01-27 GR GR920400086T patent/GR3003657T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU200919B (en) | 1990-09-28 |
| ZA881366B (en) | 1989-10-25 |
| IL85560A (en) | 1991-12-12 |
| GR3003657T3 (OSRAM) | 1993-03-16 |
| IL85560A0 (en) | 1988-08-31 |
| KR880009647A (ko) | 1988-10-04 |
| NZ223670A (en) | 1990-12-21 |
| JPS63238019A (ja) | 1988-10-04 |
| EP0280290A3 (en) | 1989-08-09 |
| DK102988A (da) | 1988-08-28 |
| CA1317229C (en) | 1993-05-04 |
| DK102988D0 (da) | 1988-02-26 |
| EP0280290B1 (de) | 1992-01-08 |
| DE3867501D1 (de) | 1992-02-20 |
| AU605554B2 (en) | 1991-01-17 |
| EP0280290A2 (de) | 1988-08-31 |
| AU1235288A (en) | 1988-09-01 |
| HUT46535A (en) | 1988-11-28 |
| US4931435A (en) | 1990-06-05 |
| US5217967A (en) | 1993-06-08 |
| DE3706399A1 (de) | 1988-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68902353D1 (de) | Hautdepigmentierungsmittel. | |
| FI921606A0 (fi) | Mikroperoxidas innehaollande hemopeptid som aktiv komponent. | |
| DE3674114D1 (de) | Pilztoetende mittel. | |
| DE3684108D1 (de) | Zementformende mittel. | |
| DE68913792D1 (de) | Synergistische antimikrobielle Zusammensetzung. | |
| DE69007507D1 (de) | Fungizides Mittel. | |
| DE3485162D1 (de) | Als antibakterielle mittel verwendbare aminomethyloxooxazolidinyl-benzol-derivate. | |
| DK17687A (da) | Antiseptiske midler | |
| DE3681145D1 (de) | Immunstimulierende mittel. | |
| FI902876A0 (fi) | Tvaettmedelspartiklar innehaollande en aktiv komponent och despergerbara i kallt vatten. | |
| DE68914495D1 (de) | Antihypercholesterolemisches Mittel. | |
| NO861509L (no) | Antibakterielle midler. | |
| NO892617L (no) | Anti-aterogene midler. | |
| DE3863861D1 (de) | Mikrobizide mittel. | |
| DE69032656D1 (de) | Akarizide Mittel | |
| DE59010922D1 (de) | Synergistische herbizide Mittel | |
| DE3767075D1 (de) | Herbizides mittel. | |
| DE3682908D1 (de) | Fungizides mittel. | |
| DE68915269D1 (de) | Polyvalentes entzündungshemmendes mittel. | |
| DE69010754D1 (de) | Fungizide Mittel. | |
| ATE100094T1 (de) | Imidazolantiarrythmische mittel. | |
| DK102988A (da) | Middel med antidepressiv virkning | |
| DD132461A5 (de) | Fungizide mittel | |
| MC2140A1 (fr) | Agent antimicrobien | |
| DD228409A7 (de) | Insektizide oder akarizide mittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |